首页 > 最新文献

Esculapio最新文献

英文 中文
Teaching During Covid-19 Covid-19期间的教学
Pub Date : 2021-01-29 DOI: 10.51273/ESC20.25164-GUESTEDITORIAL
A. M. Chaudhary
The recent outbreak of COVID-19 has enor- mously affected every aspect of global arrange- ments with its fast and lethal reach. Originating from Wuhan, a Chinese city, this highly infectious virus has forced to impose nationwide closures in many countries impacting onsite educational systems to shut down. Considering the safety of students and following the steps taken by many infected countries, the Pakistan government initially closed all the edu- cational institutions and later allowed partial opening of schools where 30-50 % of students were allowed to attend classes in a cyclic manner. The direct and most immediate impact of this decision was an untimely break and loss of learning opportunities for all students. In order to continue with teaching and learning, Higher education commission, developed online tea- ching guidelines with the instructions to resume tea- ching, by following these guidelines. The guidelines included development and implementation of both online and hybrid curricula. Online teaching-learning is based on application of information technology tools to ensure access to learning resources for all students in the absence of face to face classes. It is conducted in the form of asynchronous or synchronous communication where-in asynchronous system tools like e-mail, discussion boards, learning newsgroups are used. For synchronous system webcasting, live chat and audio/video technologies are used for realtime class. Hybrid learning can be defined as a learning approach that combines both remote learning and inperson learning to improve student experience and ensure learning continuity.
最近爆发的2019冠状病毒病以其迅速和致命的影响极大地影响了全球安排的各个方面。这种高传染性的病毒起源于中国武汉,在许多国家被迫在全国范围内关闭,影响了现场教育系统的关闭。考虑到学生的安全,并遵循许多受感染国家采取的措施,巴基斯坦政府最初关闭了所有教育机构,后来允许部分学校开放,允许30- 50%的学生以循环的方式上课。这一决定的直接和最直接的影响是不合时宜地中断和失去了所有学生的学习机会。为了继续进行教学和学习,高等教育委员会制定了在线茶艺指南,并说明了恢复茶艺的说明,并遵循这些指南。指导方针包括开发和实施在线和混合课程。在线教学是基于信息技术工具的应用,以确保所有学生在没有面对面课程的情况下获得学习资源。它以异步或同步通信的形式进行,其中使用了电子邮件、讨论板、学习新闻组等异步系统工具。对于同步系统网络广播,实时课程使用实时聊天和音频/视频技术。混合学习可以定义为一种将远程学习和现场学习相结合的学习方法,以改善学生的体验并确保学习的连续性。
{"title":"Teaching During Covid-19","authors":"A. M. Chaudhary","doi":"10.51273/ESC20.25164-GUESTEDITORIAL","DOIUrl":"https://doi.org/10.51273/ESC20.25164-GUESTEDITORIAL","url":null,"abstract":"The recent outbreak of COVID-19 has enor- mously affected every aspect of global arrange- ments with its fast and lethal reach. Originating from Wuhan, a Chinese city, this highly infectious virus has forced to impose nationwide closures in many countries impacting onsite educational systems to shut down. Considering the safety of students and following the steps taken by many infected countries, the Pakistan government initially closed all the edu- cational institutions and later allowed partial opening of schools where 30-50 % of students were allowed to attend classes in a cyclic manner. The direct and most immediate impact of this decision was an untimely break and loss of learning opportunities for all students. In order to continue with teaching and learning, Higher education commission, developed online tea- ching guidelines with the instructions to resume tea- ching, by following these guidelines. The guidelines included development and implementation of both online and hybrid curricula. Online teaching-learning is based on application of information technology tools to ensure access to learning resources for all students in the absence of face to face classes. It is conducted in the form of asynchronous or synchronous communication where-in asynchronous system tools like e-mail, discussion boards, learning newsgroups are used. For synchronous system webcasting, live chat and audio/video technologies are used for realtime class. Hybrid learning can be defined as a learning approach that combines both remote learning and inperson learning to improve student experience and ensure learning continuity.","PeriodicalId":11923,"journal":{"name":"Esculapio","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44414957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Comparison of R-CHOP with CHOP in Patients of Diffuse Large B Cell Lymphoma R-CHOP与CHOP在弥漫性大B细胞淋巴瘤中的比较
Pub Date : 2021-01-29 DOI: 10.51273/ESC20.2516417
F. R. Lodhi, Amjad Zafar, M. A. Khokhar, A. Goraya, S. Yaqub
Objective: Diffuse large B cell lymphoma (DLBCL) is a lymphoid B cells neoplasm with a diffuse pattern and high proliferation rate. Cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) was considered effective as other complicated regimens with more toxicity profile. Rituximab is a monoclonal antibody directed against CD20 positive B cell. It has good activity therapeutically in patients of DLBCL. It increases response rates and survivals when added to CHOP chemotherapy. Although R-CHOP is more effective but due to high cost of Rituximab it is usually not incorporated with chemotherapy in most of our patients and CHOP is still used extensively. Due to heterogeneity of disease and difference in ethnicity, there may be difference in outcomes of two regimens. This study will help us in tailoring our management plan that will result in better outcome of patients. Methods: 70 patients aged between 20-65 years having DLBCL were taken in this study. We rando-mized patients by lottery method into two groups. Group I received CHOP with dose of Cyclophosphamide 750mg/m2, Doxorubicin 50mg/m2, Vincristine 1.4 mg/m2 and prednisolone 40mg/m2.Chemotherapy was given on Day-1 while prednisolone was given for 5 days from Day-1 of chemotherapy. Group II received RCHOP which includes same chemotherapy with same dosage. Rituximab was included in Group II with dose of Rituximab 375 mg /m2. Each cycle was given at three weeks interval. Response in terms of CR (Complete Response), PR (Partial Response), SD (Stable Disease) or PD (Progressive Disease) was evaluated as per leukemia network after 4 cycles of chemotherapy. The quantitative variables were calculated by taking mean and standard deviation. The response was assessed in percentage and frequencies and compared by applying chi square test. Results: Group I had 37.1% while Group II had 68.6% complete response with p value of 0.019. Partial response was 48.6% in Group I while 20.0% in Group II. 14.3% in Group I and 8.6% in Group II either had stable disease or progressive disease. Conclusions: R-CHOP has superior response rates as compared to CHOP, therefore, whenever possible Rituximab should be added as target therapy in chemotherapy.
目的:弥漫性大B细胞淋巴瘤(DLBCL)是一种淋巴性B细胞肿瘤,具有弥漫性和高增殖率。环磷酰胺、阿霉素、长春新碱和泼尼松(CHOP)被认为是其他毒性更强的复杂方案。利妥昔单抗是一种针对CD20阳性B细胞的单克隆抗体。它对DLBCL患者具有良好的治疗活性。当加入CHOP化疗时,它可以提高反应率和生存率。尽管R-CHOP更有效,但由于利妥昔单抗的高成本,在我们的大多数患者中,它通常不与化疗结合,CHOP仍被广泛使用。由于疾病的异质性和种族的差异,两种方案的结果可能存在差异。这项研究将帮助我们制定管理计划,从而为患者带来更好的结果。方法:对70例年龄在20-65岁之间的DLBCL患者进行研究。我们采用抽签法将患者随机分为两组。第一组给予CHOP,环磷酰胺750mg/m2,阿霉素50mg/m2,长春新碱1.4mg/m2,泼尼松40mg/m2。化疗第1天开始化疗,泼尼松龙从化疗第1天起给药5天。第二组接受RCHOP,包括相同剂量的相同化疗。利妥昔单抗被纳入第II组,其剂量为375mg/m2。每个周期间隔三周。化疗4个周期后,根据白血病网络评估CR(完全反应)、PR(部分反应)、SD(稳定疾病)或PD(进展性疾病)的反应。通过取平均值和标准差来计算定量变量。反应以百分比和频率进行评估,并通过卡方检验进行比较。结果:Ⅰ组有37.1%的完全缓解,Ⅱ组有68.6%的完全缓解。部分缓解率在第一组为48.6%,而在第二组为20.0%。I组14.3%和II组8.6%的患者病情稳定或进展。结论:与CHOP相比,R-CHOP的有效率更高,因此,在化疗中应尽可能添加利妥昔单抗作为靶向治疗。
{"title":"Comparison of R-CHOP with CHOP in Patients of Diffuse Large B Cell Lymphoma","authors":"F. R. Lodhi, Amjad Zafar, M. A. Khokhar, A. Goraya, S. Yaqub","doi":"10.51273/ESC20.2516417","DOIUrl":"https://doi.org/10.51273/ESC20.2516417","url":null,"abstract":"Objective: Diffuse large B cell lymphoma (DLBCL) is a lymphoid B cells neoplasm with a diffuse pattern and high proliferation rate. Cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) was considered effective as other complicated regimens with more toxicity profile. Rituximab is a monoclonal antibody directed against CD20 positive B cell. It has good activity therapeutically in patients of DLBCL. It increases response rates and survivals when added to CHOP chemotherapy. Although R-CHOP is more effective but due to high cost of Rituximab it is usually not incorporated with chemotherapy in most of our patients and CHOP is still used extensively. Due to heterogeneity of disease and difference in ethnicity, there may be difference in outcomes of two regimens. This study will help us in tailoring our management plan that will result in better outcome of patients. Methods: 70 patients aged between 20-65 years having DLBCL were taken in this study. We rando-mized patients by lottery method into two groups. Group I received CHOP with dose of Cyclophosphamide 750mg/m2, Doxorubicin 50mg/m2, Vincristine 1.4 mg/m2 and prednisolone 40mg/m2.Chemotherapy was given on Day-1 while prednisolone was given for 5 days from Day-1 of chemotherapy. Group II received RCHOP which includes same chemotherapy with same dosage. Rituximab was included in Group II with dose of Rituximab 375 mg /m2. Each cycle was given at three weeks interval. Response in terms of CR (Complete Response), PR (Partial Response), SD (Stable Disease) or PD (Progressive Disease) was evaluated as per leukemia network after 4 cycles of chemotherapy. The quantitative variables were calculated by taking mean and standard deviation. The response was assessed in percentage and frequencies and compared by applying chi square test. Results: Group I had 37.1% while Group II had 68.6% complete response with p value of 0.019. Partial response was 48.6% in Group I while 20.0% in Group II. 14.3% in Group I and 8.6% in Group II either had stable disease or progressive disease. Conclusions: R-CHOP has superior response rates as compared to CHOP, therefore, whenever possible Rituximab should be added as target therapy in chemotherapy.","PeriodicalId":11923,"journal":{"name":"Esculapio","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49630305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency and Severity of Premenstrual Syndrome among Undergraduate Medical Students 医学本科生月经前综合征的发生频率和严重程度
Pub Date : 2021-01-29 DOI: 10.51273/ESC20.251646
S. Yunus, Bushra Bano, Ayesha Farooq, Amtullah Zarreen
Objective: To find out the frequency and to assess the degree of severity of premenstrual syndrome among undergraduate medical students Methods:Methods: It is a Cross-Sectional Study conducted in 161 female Students of Allama Iqbal Medical College of 1st year to final year who voluntarily consented for participation. PMS and its severity was diagnosed on the basis of a modified DRSP scale: mild if the score is 50-85, moderate if the score is 86120 and severe if the score is >120. Females having irregular periods or any organic pathology and those using hormonal contraception or any medication were excluded.Data was analyzed by SPSS version 23. Frequency, percentage charting was expressed for variables like presence of PMS and severity of PMS. Quantitative variables like age and BMI were expressed by Mean±S.D. Data was stratified for age, BMI, year of study, living status and marital status to deal with effect modifiers. Test of significance was applied i.e chisquare. A p-value ≤0.05 was considered significant. Results: Subjects ranged between 18-25 years with mean age of 19.9±2.1 years. Majority of the students were between 18-20 years. Mean BMI was 19.9±1.9 kg/m2. Mean year of study was 2.4±1.3 year. Out of 161 subjects, 53 (32.9%) were living with parents while remaining 108 (67.1%) were far from parents. Married students were 10 (6.2%). Premenstrual syndrome was found to be in 31 females (19.2%), mild 4.3%, moderate 8.1% and severe 6.8%,and severity was more in 4-5 years students, p-value was found significant with variable years of study (p-value= 0.095). Conclusion: PMS was found in 19.2% of undergraduate medical students. Early recognition and timely management can improve the quality of performance among undergraduates.
目的:了解医学生经前综合征的发生频率及严重程度。方法:对161名自愿参加的阿拉马伊克巴尔医学院大一至大四女学生进行横断面调查。经前综合症及其严重程度根据改良DRSP量表进行诊断:50-85分为轻度,86120分为中度,bb0 - 120分为重度。有月经不规律或器质性病变的女性以及使用激素避孕或任何药物的女性被排除在外。数据采用SPSS version 23进行分析。频率,百分比图表表示变量如经前症候群的存在和严重程度。年龄、BMI等定量变量以Mean±sd表示根据年龄、BMI、研究年份、生活状况和婚姻状况对数据进行分层,处理影响因子。采用显著性检验,即凿方检验。A p值≤0.05被认为是显著的。结果:受试者年龄18 ~ 25岁,平均年龄19.9±2.1岁。大多数学生年龄在18-20岁之间。平均BMI为19.9±1.9 kg/m2。平均研究年为2.4±1.3年。161名受试者中,53名(32.9%)与父母同住,108名(67.1%)远离父母。已婚学生10名(6.2%)。经前综合征女性31人(19.2%),轻度4.3%,中度8.1%,重度6.8%,其中4-5年级学生的严重程度更高,p值与学习年限差异有统计学意义(p值= 0.095)。结论:经前症候群发生率为19.2%。早期发现和及时管理可以提高大学生的绩效质量。
{"title":"Frequency and Severity of Premenstrual Syndrome among Undergraduate Medical Students","authors":"S. Yunus, Bushra Bano, Ayesha Farooq, Amtullah Zarreen","doi":"10.51273/ESC20.251646","DOIUrl":"https://doi.org/10.51273/ESC20.251646","url":null,"abstract":"Objective: To find out the frequency and to assess the degree of severity of premenstrual syndrome among undergraduate medical students Methods:Methods: It is a Cross-Sectional Study conducted in 161 female Students of Allama Iqbal Medical College of 1st year to final year who voluntarily consented for participation. PMS and its severity was diagnosed on the basis of a modified DRSP scale: mild if the score is 50-85, moderate if the score is 86120 and severe if the score is >120. Females having irregular periods or any organic pathology and those using hormonal contraception or any medication were excluded.Data was analyzed by SPSS version 23. Frequency, percentage charting was expressed for variables like presence of PMS and severity of PMS. Quantitative variables like age and BMI were expressed by Mean±S.D. Data was stratified for age, BMI, year of study, living status and marital status to deal with effect modifiers. Test of significance was applied i.e chisquare. A p-value ≤0.05 was considered significant. Results: Subjects ranged between 18-25 years with mean age of 19.9±2.1 years. Majority of the students were between 18-20 years. Mean BMI was 19.9±1.9 kg/m2. Mean year of study was 2.4±1.3 year. Out of 161 subjects, 53 (32.9%) were living with parents while remaining 108 (67.1%) were far from parents. Married students were 10 (6.2%). Premenstrual syndrome was found to be in 31 females (19.2%), mild 4.3%, moderate 8.1% and severe 6.8%,and severity was more in 4-5 years students, p-value was found significant with variable years of study (p-value= 0.095). Conclusion: PMS was found in 19.2% of undergraduate medical students. Early recognition and timely management can improve the quality of performance among undergraduates.","PeriodicalId":11923,"journal":{"name":"Esculapio","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44204874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Knowledge About Autism Spectrum Disorder Among Paediatricians 儿科医生对自闭症谱系障碍知识的评估
Pub Date : 2021-01-29 DOI: 10.51273/ESC20.2516418
Fatima Zia, Hafsa Qamar, I. Aslam, M. Siddiqui
Objective: To evaluate the frequency of Paediatricians who have good knowledge for diagnosis of Autism Spectrum Disorder (ASD). Methods: It is cross-sectional study conducted in department of Paediatric Medicine, Children Hospital, Lahore, Jinnah Hospital and Services Hospital Lahore, in 6 months duration, spanning from June 27, 2016 till December 27, 2016. A total of 89 doctors fulfilling the inclusion criteria were registered after informed consent. Demographic data (including age, sex, qualification and duration of clinical experience) was taken. Doctors were given a questionnaire to assess their knowledge of ASD. The questionnaire was a nineteen-item self-administered questionnaire divided into four domains namely, social interaction (Domain 1), impairment in communication (Domain 2), repetitive behavior (Domain 3), characteristics of autism as a disorder and its comorbidities (Domain 4). The KCAHW sore ≥ 15 was considered as good. Data was entered and analyzed in (SPSS) version 22.0. Results: The mean age of subjects was 30.67±2.80 years with 31(31%) physicians male and 69(69%) were females. The mean KCAHW score was 15.07±3.54 with minimum and maximum score of 7 and 19. According to operational definition a total of 62(62%) subjects had good knowledge while 38(38%) physician had score < 15. Conclusion: Though 68% of paediatricians had good knowledge about childhood autism according to our study. The physicians who had poor knowledge, must be considered for different educational activities to enhance their knowledge regarding ASD, which may help in early diagnosis and improving prognosis of children with ASD. Key Words: Paediatricians, Autism spectrum disorder How to Cite: Zia F, Qamar H, Aslam I, Siddiqui MA. Assessment of knowledge about autism spectrum disorder among paediatricians. Esculapio.2020;16(04):83-86.
目的:评价掌握自闭症谱系障碍(ASD)诊断知识的儿科医生的患病率。方法:这是一项横断面研究,在拉合尔儿童医院儿科、拉合尔真纳医院和拉合尔服务医院进行,为期6个月,从2016年6月27日至2016年12月27日。共有89名符合入选标准的医生在知情同意后注册。采集人口统计学数据(包括年龄、性别、资格和临床经验持续时间)。医生们收到了一份问卷,以评估他们对ASD的了解。该问卷是一份19项的自我管理问卷,分为四个领域,即社交互动(领域1)、沟通障碍(领域2)、重复行为(领域3)、自闭症作为一种障碍的特征及其合并症(领域4)。KCAHW疼痛≥15被认为是好的。数据在(SPSS)22.0版中输入并分析。结果:受试者的平均年龄为30.67±2.80岁,其中31名(31%)医生为男性,69名(69%)医生为女性。KCAHW平均得分为15.07±3.54,最小和最大得分分别为7和19。根据操作定义,共有62名(62%)受试者具有良好的知识,而38名(38%)医生的得分<15。结论:尽管根据我们的研究,68%的儿科医生对儿童自闭症有很好的了解。必须考虑知识贫乏的医生进行不同的教育活动,以提高他们对ASD的知识,这可能有助于ASD儿童的早期诊断和改善预后。关键词:儿科医生,孤独症谱系障碍如何引用:Zia F,Qamar H,Aslam I,Siddiqui MA。儿科医生对孤独症谱系障碍知识的评估。埃斯库拉皮奥.2020;16(04):83-86。
{"title":"Assessment of Knowledge About Autism Spectrum Disorder Among Paediatricians","authors":"Fatima Zia, Hafsa Qamar, I. Aslam, M. Siddiqui","doi":"10.51273/ESC20.2516418","DOIUrl":"https://doi.org/10.51273/ESC20.2516418","url":null,"abstract":"Objective: To evaluate the frequency of Paediatricians who have good knowledge for diagnosis of Autism Spectrum Disorder (ASD). Methods: It is cross-sectional study conducted in department of Paediatric Medicine, Children Hospital, Lahore, Jinnah Hospital and Services Hospital Lahore, in 6 months duration, spanning from June 27, 2016 till December 27, 2016. A total of 89 doctors fulfilling the inclusion criteria were registered after informed consent. Demographic data (including age, sex, qualification and duration of clinical experience) was taken. Doctors were given a questionnaire to assess their knowledge of ASD. The questionnaire was a nineteen-item self-administered questionnaire divided into four domains namely, social interaction (Domain 1), impairment in communication (Domain 2), repetitive behavior (Domain 3), characteristics of autism as a disorder and its comorbidities (Domain 4). The KCAHW sore ≥ 15 was considered as good. Data was entered and analyzed in (SPSS) version 22.0. Results: The mean age of subjects was 30.67±2.80 years with 31(31%) physicians male and 69(69%) were females. The mean KCAHW score was 15.07±3.54 with minimum and maximum score of 7 and 19. According to operational definition a total of 62(62%) subjects had good knowledge while 38(38%) physician had score < 15. Conclusion: Though 68% of paediatricians had good knowledge about childhood autism according to our study. The physicians who had poor knowledge, must be considered for different educational activities to enhance their knowledge regarding ASD, which may help in early diagnosis and improving prognosis of children with ASD. Key Words: Paediatricians, Autism spectrum disorder How to Cite: Zia F, Qamar H, Aslam I, Siddiqui MA. Assessment of knowledge about autism spectrum disorder among paediatricians. Esculapio.2020;16(04):83-86.","PeriodicalId":11923,"journal":{"name":"Esculapio","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49129344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective Effect of Enterococcus faecium SF68 and Saccharomyces boulardii in Acute Severe Diarrhea in Infants: Randomized Controlled Trial 屎肠球菌SF68和博氏酵母菌对婴幼儿急性严重腹泻的保护作用:随机对照试验
Pub Date : 2021-01-29 DOI: 10.51273/ESC20.2516413
Fariha Khan, M. Z. Khan, A. M. Rehan, Zoobia Irum, F. Perveen, S. Chiragh
Objectives: This study was done to observe the effect of Enterococcus faecium SF68 and Saccharomyces boulardii in acute severe diarrhea in infants. Methods: It was a single blind, randomized controlled clinical trial done in Children Hospital, Lahore. The infants were selected between 6 months to 12 months of age. All the infants were suffering from acute diarrhea with severe dehydration. Total 105 infants were selected and randomly divided into three groups having 35 infants in each group. Infants in group A received standard treatment of diarrhea. Infants in group B and C received Enterococcus faecium SF68 and Saccharomyces boulardii respectively twice daily for five days along with standard treatment of diarrhea. All the infants were monitored for five days. The treatment response was observed in terms of frequency of diarrhea, duration of diarrhea, stool consistency and length of hospital stay. Results: The frequency of diarrhea, duration of diarrhea and length of hospital stay were significantly reduced in both group B and C as compared to group A. Conclusion: Enterococcus faecium SF68 and Saccharomyces boulardii helped to reduce the stool frequency, duration of diarrhea, length of hospital stay and also improved the stool consistency in acute severe diarrhea in infants.
目的:观察屎肠球菌SF68和博氏酵母菌在婴幼儿急性重症腹泻中的作用。方法:在拉合尔儿童医院进行单盲、随机对照临床试验。这些婴儿的年龄在6个月到12个月之间。所有婴儿都患有严重脱水的急性腹泻。105名婴儿被随机分为三组,每组35名婴儿。A组患儿接受腹泻标准治疗。B组和C组婴儿分别给予粪肠球菌SF68和博氏酵母菌,每日2次,连续5天,并给予腹泻标准治疗。所有的婴儿都被监测了5天。从腹泻频率、腹泻持续时间、粪便稠度和住院时间等方面观察治疗效果。结果:与a组相比,B组和C组患儿腹泻次数、腹泻持续时间和住院时间均明显减少。结论:粪肠球菌SF68和博氏酵母菌对婴幼儿急性重症腹泻患儿的大便次数、腹泻持续时间、住院时间均有降低作用,并改善大便一致性。
{"title":"Protective Effect of Enterococcus faecium SF68 and Saccharomyces boulardii in Acute Severe Diarrhea in Infants: Randomized Controlled Trial","authors":"Fariha Khan, M. Z. Khan, A. M. Rehan, Zoobia Irum, F. Perveen, S. Chiragh","doi":"10.51273/ESC20.2516413","DOIUrl":"https://doi.org/10.51273/ESC20.2516413","url":null,"abstract":"Objectives: This study was done to observe the effect of Enterococcus faecium SF68 and Saccharomyces boulardii in acute severe diarrhea in infants. Methods: It was a single blind, randomized controlled clinical trial done in Children Hospital, Lahore. The infants were selected between 6 months to 12 months of age. All the infants were suffering from acute diarrhea with severe dehydration. Total 105 infants were selected and randomly divided into three groups having 35 infants in each group. Infants in group A received standard treatment of diarrhea. Infants in group B and C received Enterococcus faecium SF68 and Saccharomyces boulardii respectively twice daily for five days along with standard treatment of diarrhea. All the infants were monitored for five days. The treatment response was observed in terms of frequency of diarrhea, duration of diarrhea, stool consistency and length of hospital stay. Results: The frequency of diarrhea, duration of diarrhea and length of hospital stay were significantly reduced in both group B and C as compared to group A. Conclusion: Enterococcus faecium SF68 and Saccharomyces boulardii helped to reduce the stool frequency, duration of diarrhea, length of hospital stay and also improved the stool consistency in acute severe diarrhea in infants.","PeriodicalId":11923,"journal":{"name":"Esculapio","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48297259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Antidiabetic Treatment with the Type of Obesity in Type 2 Diabetic Patients 抗糖尿病治疗与2型糖尿病患者肥胖类型的关系
Pub Date : 2021-01-29 DOI: 10.51273/ESC20.2516421
Jawariea Ali, Sheikh Sajjad Ali, M. Imran, T. Tariq, Umair Mahmood, J. Iqbal
Objective: To find association between antidiabetic treatment and the type of obesity in type 2 diabetic patients. Methods: The study was conducted in National Institute of Diabetes & Endocrinology (NIDE), Karachi, over a period of 6 months, ie. from January to June, 2018. It was an observational analytical study, for which 59 patients were selected via non-probability sampling, as per inclusion and exclusion criteria. Data was collected through detailed history, examination. A database was developed and analyzed on SPSS 17. A pvalue <0.05 was taken as statistically significant. Results: Fifty nine patients fulfilling the inclusion criteria were included in this study. While 30 (50.8%) had generalized obesity, 29 (49.2%) were not having generalized obesity. Further it was observed that 35 (59.3%) had abdominal obesity, while 24 (40.7%) were not having abdominal obesity. A total of 39 (66.1%) were on insulin, while 20 (43.9%) were not on insulin. Finally, 41 (69.5%) were on oral hypoglycemic drugs, while 18 (30.5%) were not on oral hypoglycemic drugs. P-values were not significant for the study parameters. Conclusion: There is no association between antidiabetic treatment and type of obesity in type 2 diabetic patients.
目的:探讨2型糖尿病患者抗糖尿病治疗与肥胖类型的关系。方法:研究在卡拉奇国家糖尿病与内分泌研究所(NIDE)进行,为期6个月。2018年1月至6月。这是一项观察性分析研究,根据纳入和排除标准,通过非概率抽样选择了59例患者。资料收集通过详细的历史,检查。在SPSS 17软件中建立数据库并进行分析。p值<0.05为差异有统计学意义。结果:59例符合纳入标准的患者纳入本研究。30例(50.8%)为全身性肥胖,29例(49.2%)为非全身性肥胖。进一步观察到35人(59.3%)有腹部肥胖,24人(40.7%)没有腹部肥胖。39例(66.1%)接受胰岛素治疗,20例(43.9%)未接受胰岛素治疗。口服降糖药41例(69.5%),未口服降糖药18例(30.5%)。研究参数的p值不显著。结论:2型糖尿病患者抗糖尿病治疗与肥胖类型无相关性。
{"title":"Association of Antidiabetic Treatment with the Type of Obesity in Type 2 Diabetic Patients","authors":"Jawariea Ali, Sheikh Sajjad Ali, M. Imran, T. Tariq, Umair Mahmood, J. Iqbal","doi":"10.51273/ESC20.2516421","DOIUrl":"https://doi.org/10.51273/ESC20.2516421","url":null,"abstract":"Objective: To find association between antidiabetic treatment and the type of obesity in type 2 diabetic patients. Methods: The study was conducted in National Institute of Diabetes & Endocrinology (NIDE), Karachi, over a period of 6 months, ie. from January to June, 2018. It was an observational analytical study, for which 59 patients were selected via non-probability sampling, as per inclusion and exclusion criteria. Data was collected through detailed history, examination. A database was developed and analyzed on SPSS 17. A pvalue <0.05 was taken as statistically significant. Results: Fifty nine patients fulfilling the inclusion criteria were included in this study. While 30 (50.8%) had generalized obesity, 29 (49.2%) were not having generalized obesity. Further it was observed that 35 (59.3%) had abdominal obesity, while 24 (40.7%) were not having abdominal obesity. A total of 39 (66.1%) were on insulin, while 20 (43.9%) were not on insulin. Finally, 41 (69.5%) were on oral hypoglycemic drugs, while 18 (30.5%) were not on oral hypoglycemic drugs. P-values were not significant for the study parameters. Conclusion: There is no association between antidiabetic treatment and type of obesity in type 2 diabetic patients.","PeriodicalId":11923,"journal":{"name":"Esculapio","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44076704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing the Efficacy of Hyaluronic Acid and Platelet Rich Plasma Treatment by using Visual analogue Scale in the Patients of Knee Osteoarthritis 用视觉模拟量表比较透明质酸与富血小板血浆治疗膝关节骨性关节炎的疗效
Pub Date : 2021-01-29 DOI: 10.51273/ESC20.251648
Muhammad Ali, M. Azam, Maimoona Zaheer, Fahad Wali Shah Khagha, A. Shah, F. Masood
Objective: To compare the efficacy of Hyaluronic acid (HA) and Platelet rich plasma (PRP) for treatment of Knee osteoarthritis. Methods: A randomized controlled trial done at department of Orthopedics Unit-I, Mayo Hospital Lahore. 130 cases fulfilling inclusion criteria were enrolled. All patients were divided into two groups. In group-A, cases were treated with HA (1% sodium Hyaluronate mixed in a phosphate buffered saline). In group-B, cases were treated with 10ml of PRP extracted from 100ml of their blood. Before and after procedure pain and efficacy was recorded. Results: The frequency of pain reduction ≥ 50% was statistically higher in PRP group as compared to HA group, p-value < 0.05. Conclusion: Through the findings of this study we conclude that the efficacy of efficacy of PRP was high than HA for treatment of Knee osteoarthritis.
目的:比较透明质酸(HA)和富血小板血浆(PRP)治疗膝骨关节炎的疗效。方法:在拉合尔梅奥医院第一骨科进行随机对照试验。130例符合纳入标准的病例被纳入。所有患者被分为两组。在A组中,病例用HA(1%透明质酸钠混合在磷酸盐缓冲盐水中)治疗。在B组中,病例用从100毫升血液中提取的10毫升PRP进行治疗。记录手术前后的疼痛和疗效。结果:与HA组相比,PRP组疼痛减轻≥50%的频率在统计学上更高,p值<0.05。结论:通过本研究的结果,我们得出结论,PRP治疗膝骨关节炎的疗效高于HA。
{"title":"Comparing the Efficacy of Hyaluronic Acid and Platelet Rich Plasma Treatment by using Visual analogue Scale in the Patients of Knee Osteoarthritis","authors":"Muhammad Ali, M. Azam, Maimoona Zaheer, Fahad Wali Shah Khagha, A. Shah, F. Masood","doi":"10.51273/ESC20.251648","DOIUrl":"https://doi.org/10.51273/ESC20.251648","url":null,"abstract":"Objective: To compare the efficacy of Hyaluronic acid (HA) and Platelet rich plasma (PRP) for treatment of Knee osteoarthritis. Methods: A randomized controlled trial done at department of Orthopedics Unit-I, Mayo Hospital Lahore. 130 cases fulfilling inclusion criteria were enrolled. All patients were divided into two groups. In group-A, cases were treated with HA (1% sodium Hyaluronate mixed in a phosphate buffered saline). In group-B, cases were treated with 10ml of PRP extracted from 100ml of their blood. Before and after procedure pain and efficacy was recorded. Results: The frequency of pain reduction ≥ 50% was statistically higher in PRP group as compared to HA group, p-value < 0.05. Conclusion: Through the findings of this study we conclude that the efficacy of efficacy of PRP was high than HA for treatment of Knee osteoarthritis.","PeriodicalId":11923,"journal":{"name":"Esculapio","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42207685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparison between Bupivacaine Alone and Bupivacaine with Tramadol in Epidural Block for Postoperative Pain Management 布比卡因单用与布比卡因联合曲马多用于硬膜外阻滞治疗术后疼痛的比较
Pub Date : 2021-01-29 DOI: 10.51273/ESC20.2516422
S. Khaleeq, Azib Ali, Sahir Shafiq, M. M. Butt, M. Aslam, M. Jehangir
Objective: This study was designed to compare the mean pain score with bupivacaine versus tramadol plus bupivacaine in patients undergoing surgery under general anesthesia. Randomized Controlled Study. Anesthesia department of SIMS medical college/Services Hospital, Lahore. Duration is 13 months from 20th August2017 till 24th September 2018. Method: 80 patients aged 20-60 years of ASA I & II status, undergoing elective surgery were selected. Patients were randomly divided into two groups (Group A and B) of 40 each, using random numbers table. An epidural catheter was placed at L3-L4 intervertebral level. Group A was given 30 ml of 0.125% bupivacaine and Group B was given 25mg Tramadol plus 0.125% bupivacaine mixture in the same volume. General anesthesia was induced with IV Propofol 2mg/kg and atracurium 0.5mg/kg. After recovery from anesthesia, patients were shifted to HDU. Post-operative pain was assessed using the 10-point VAS score. Injection nalbuphine 0.1mg/kg was given as rescue analgesic when VAS score became more than 4. Results: The mean age of patient in Group A was 37.5 ± 9.1 years and 38.6 ± 7.0 years in Group B. Mean BMI in Group A was 33.2 ± 4.3 and 32.2 ± 4.2 in Group B. The mean pain score after 12 hours of surgery was 3.6 ± 0.8 in Group A and 1.5 ± 0.9 in Group B, p value was significant. Conclusion: Thus, the present study concludes that epidural administration of tramadol as adjuvant with bupivacaine is more effective in postoperative pain relief as compared to bupivacaine alone.
目的:本研究旨在比较布比卡因与曲马多加布比卡因在全身麻醉下手术患者的平均疼痛评分。随机对照研究。拉合尔SIMS医学院/服务医院麻醉科。期限为13个月,从2017年8月20日至2018年9月24日。方法:选择80例年龄20 ~ 60岁的ASA I、II级患者,行择期手术。采用随机数字表法将患者随机分为A、B两组,每组40例。硬膜外导管放置在L3-L4椎间水平。A组给予0.125%布比卡因30 ml, B组给予曲马多加0.125%布比卡因等量混合物25mg。静脉注射异丙酚2mg/kg、阿曲库铵0.5mg/kg诱导全身麻醉。麻醉恢复后,患者转至HDU。术后疼痛采用10分VAS评分进行评估。VAS评分大于4分时,给予静脉注射纳布啡0.1mg/kg作为抢救性镇痛药。结果:A组患者的平均年龄为37.5±9.1岁,B组患者的平均年龄为38.6±7.0岁,A组患者的平均BMI为33.2±4.3岁,B组患者的平均BMI为32.2±4.2岁。A组患者术后12小时的平均疼痛评分为3.6±0.8分,B组患者的平均疼痛评分为1.5±0.9分,p值有显著性差异。结论:因此,本研究得出结论,与单独布比卡因相比,硬膜外给药曲马多作为辅助布比卡因在术后疼痛缓解方面更有效。
{"title":"A Comparison between Bupivacaine Alone and Bupivacaine with Tramadol in Epidural Block for Postoperative Pain Management","authors":"S. Khaleeq, Azib Ali, Sahir Shafiq, M. M. Butt, M. Aslam, M. Jehangir","doi":"10.51273/ESC20.2516422","DOIUrl":"https://doi.org/10.51273/ESC20.2516422","url":null,"abstract":"Objective: This study was designed to compare the mean pain score with bupivacaine versus tramadol plus bupivacaine in patients undergoing surgery under general anesthesia. Randomized Controlled Study. Anesthesia department of SIMS medical college/Services Hospital, Lahore. Duration is 13 months from 20th August2017 till 24th September 2018. Method: 80 patients aged 20-60 years of ASA I & II status, undergoing elective surgery were selected. Patients were randomly divided into two groups (Group A and B) of 40 each, using random numbers table. An epidural catheter was placed at L3-L4 intervertebral level. Group A was given 30 ml of 0.125% bupivacaine and Group B was given 25mg Tramadol plus 0.125% bupivacaine mixture in the same volume. General anesthesia was induced with IV Propofol 2mg/kg and atracurium 0.5mg/kg. After recovery from anesthesia, patients were shifted to HDU. Post-operative pain was assessed using the 10-point VAS score. Injection nalbuphine 0.1mg/kg was given as rescue analgesic when VAS score became more than 4. Results: The mean age of patient in Group A was 37.5 ± 9.1 years and 38.6 ± 7.0 years in Group B. Mean BMI in Group A was 33.2 ± 4.3 and 32.2 ± 4.2 in Group B. The mean pain score after 12 hours of surgery was 3.6 ± 0.8 in Group A and 1.5 ± 0.9 in Group B, p value was significant. Conclusion: Thus, the present study concludes that epidural administration of tramadol as adjuvant with bupivacaine is more effective in postoperative pain relief as compared to bupivacaine alone.","PeriodicalId":11923,"journal":{"name":"Esculapio","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47214918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency of Weight Gain and its Impact in Adults during Lockdown: A Cross- Sectional Study 闭锁期间成人体重增加频率及其影响:一项横断面研究
Pub Date : 2021-01-29 DOI: 10.51273/ESC20.2516424
Uswah Bokhari, Uswah Shoaib, S. Tariq, S. Khan, Fatima Syed, B. Amin, Farhat Ijaz, Rana Khurram Aftab
Objectives: The current lockdown in the country has led to a sedentary lifestyle because of a shift of daily activities online and a fear of contracting the illness leading to isolation inside homes; Hence an expected change in weight of the general population. This study aims to determine the frequency of weight gain and its impact in adults during the current lockdown of COVID-19. Methods: Participants selected from the ages of 18-25 from different universities of Pakistan were sent questionnaires via WhatsApp, posted online using Microsoft Forms. A total of 157 responses were attained. Results: Among the 157 participants the average weight before the lockdown was 61.95 kgs and after the lockdown was 64.99kgs so there was an increase of 3.016 kgs whereas 18.5% of the sample maintained their weight and 37.6% were reported to have lost weight. The results also depict a 1.6% increase in impairment of body image. Conclusion: We concluded that the Lockdown due to the COVID-19 pandemic has caused a gain in the weight and lowered self-esteem with regard to body image of most young adults in Pakistan due to many factors including higher food intake, lack of exercise and also emotional distress.
目标:目前该国的封锁导致人们习惯了久坐不动的生活方式,因为日常活动转移到网上,人们担心感染这种疾病,导致自己被隔离在家中;因此总体体重的预期变化。本研究旨在确定在当前COVID-19封锁期间体重增加的频率及其对成年人的影响。方法:选取来自巴基斯坦不同大学的18-25岁的参与者,通过WhatsApp发送问卷,并使用Microsoft Forms在线发布。共获得157份答复。结果:在157名参与者中,封锁前的平均体重为61.95公斤,封锁后的平均体重为64.99公斤,因此增加了3.016公斤,而18.5%的样本保持体重,37.6%的样本报告体重减轻。结果还显示,身体形象受损的比例增加了1.6%。结论:我们得出的结论是,由于许多因素,包括食物摄入量增加、缺乏锻炼和情绪困扰,2019冠状病毒病大流行造成的封锁导致巴基斯坦大多数年轻人体重增加,对身体形象的自尊心降低。
{"title":"Frequency of Weight Gain and its Impact in Adults during Lockdown: A Cross- Sectional Study","authors":"Uswah Bokhari, Uswah Shoaib, S. Tariq, S. Khan, Fatima Syed, B. Amin, Farhat Ijaz, Rana Khurram Aftab","doi":"10.51273/ESC20.2516424","DOIUrl":"https://doi.org/10.51273/ESC20.2516424","url":null,"abstract":"Objectives: The current lockdown in the country has led to a sedentary lifestyle because of a shift of daily activities online and a fear of contracting the illness leading to isolation inside homes; Hence an expected change in weight of the general population. This study aims to determine the frequency of weight gain and its impact in adults during the current lockdown of COVID-19. Methods: Participants selected from the ages of 18-25 from different universities of Pakistan were sent questionnaires via WhatsApp, posted online using Microsoft Forms. A total of 157 responses were attained. Results: Among the 157 participants the average weight before the lockdown was 61.95 kgs and after the lockdown was 64.99kgs so there was an increase of 3.016 kgs whereas 18.5% of the sample maintained their weight and 37.6% were reported to have lost weight. The results also depict a 1.6% increase in impairment of body image. Conclusion: We concluded that the Lockdown due to the COVID-19 pandemic has caused a gain in the weight and lowered self-esteem with regard to body image of most young adults in Pakistan due to many factors including higher food intake, lack of exercise and also emotional distress.","PeriodicalId":11923,"journal":{"name":"Esculapio","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41988877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Ovulation Induction with Letrozole with Metformin Versus Letrozole Alone in Females Presenting with Polycystic Ovarian Syndrome 来曲唑联合二甲双胍与单独来曲唑对多囊卵巢综合征女性促排卵效果的比较
Pub Date : 2021-01-29 DOI: 10.51273/ESC20.2516412
Zubda Aiman, Amna Khanam, Mahliqa Maqsood, Mehwish Ayyaz, M. Alía, Tayyaba Kanwal
Objective: To compare the frequency of Ovulation Induction after administration of Letrozole with metformin versus Letrozole alone in females presenting with Polycystic Ovarian Syndrome Methods: This Randomized Controlled Trial was done in unit 5 of Lady Aitchison Hospital Lahore for 6 months. Total 200 females fulfilling the inclusion criteria were recruited from OPD. Lottery method was used for randomization of study subjects. Females in group A were given Letrozole 2.5mg once a day for five days (from third to seventh day)of the cycle for three consecutive months and metformin 1500mg (500mg 3 times a day) daily for three months, while females in group B were given Letrozole 2.5mg once a day for five days (from third to seventh day) le for three consecutive months. Then they were followed up in OPD for 3 cycles. In all 3 cycles TVS was done on day 12 to access the number of follicles and to measure the size of largest follicle, and on day 21 of cycle progesterone level will be assessed for confirmation of ovulation induction. The data was entered and analyzed through SPSS version 20. Mean and standard deviation was calculated for age and BMI. Frequency and percentage was calculated for Ovulation induction. Both groups were compared by using chi-square test taking p-value<0.05 as significant. Data was stratified for BMI (Normal, overweight and Obese).After stratification chi-square test was applied keeping a p value < 0.05 as significant. Results: In Group-A mean age of women was 28.18±6.58 years. In Group-B mean age of women was 27.08±5.15 years. In Group-A ovulation induction rate was much higher as compared to that of Group-B women. i.e. (89% vs. 60%). p-value=0.000. Ovulation induction rate was significantly higher with Letrozole+ Metformin in women who were having normal BMI, overweight & obese as compared to that of Letrozole alone. Conclusion: Letrozole with metformin is more effective for the ovulation Induction females presenting with polycystic ovarian Syndrome as compared to letrozole alone.()
目的:比较多囊卵巢综合征女性来曲唑联合二甲双胍与单独来曲唑诱导排卵的频率。方法:本随机对照试验在拉合尔艾奇逊夫人医院第五单元进行,为期6个月。从门诊部共招募了200名符合纳入标准的女性。采用抽签法对研究对象进行随机化。A组女性给予来曲唑2.5mg /天1次,连续3个月,连续5天(第3 ~ 7天),二甲双胍1500mg (500mg /天3次),连续3个月,B组女性给予来曲唑2.5mg /天1次,连续5天(第3 ~ 7天),连续3个月。随访3个周期。在所有3个周期中,在第12天进行TVS以获取卵泡数量并测量最大卵泡的大小,在第21天评估黄体酮水平以确认促排卵。通过SPSS version 20录入数据并进行分析。计算年龄和BMI的平均值和标准差。计算促排卵次数和百分比。两组比较采用卡方检验,p值<0.05为差异有统计学意义。数据按BMI(正常、超重和肥胖)分层。分层后采用卡方检验,p < 0.05为显著性。结果:a组女性平均年龄28.18±6.58岁。b组女性平均年龄27.08±5.15岁。a组诱导排卵率明显高于b组。即(89% vs. 60%)。假定值= 0.000。在BMI正常、超重和肥胖的女性中,来曲唑+二甲双胍的促排卵率明显高于单独来曲唑。结论:来曲唑联合二甲双胍治疗多囊卵巢综合征的效果优于单独来曲唑。
{"title":"Comparison of Ovulation Induction with Letrozole with Metformin Versus Letrozole Alone in Females Presenting with Polycystic Ovarian Syndrome","authors":"Zubda Aiman, Amna Khanam, Mahliqa Maqsood, Mehwish Ayyaz, M. Alía, Tayyaba Kanwal","doi":"10.51273/ESC20.2516412","DOIUrl":"https://doi.org/10.51273/ESC20.2516412","url":null,"abstract":"Objective: To compare the frequency of Ovulation Induction after administration of Letrozole with metformin versus Letrozole alone in females presenting with Polycystic Ovarian Syndrome Methods: This Randomized Controlled Trial was done in unit 5 of Lady Aitchison Hospital Lahore for 6 months. Total 200 females fulfilling the inclusion criteria were recruited from OPD. Lottery method was used for randomization of study subjects. Females in group A were given Letrozole 2.5mg once a day for five days (from third to seventh day)of the cycle for three consecutive months and metformin 1500mg (500mg 3 times a day) daily for three months, while females in group B were given Letrozole 2.5mg once a day for five days (from third to seventh day) le for three consecutive months. Then they were followed up in OPD for 3 cycles. In all 3 cycles TVS was done on day 12 to access the number of follicles and to measure the size of largest follicle, and on day 21 of cycle progesterone level will be assessed for confirmation of ovulation induction. The data was entered and analyzed through SPSS version 20. Mean and standard deviation was calculated for age and BMI. Frequency and percentage was calculated for Ovulation induction. Both groups were compared by using chi-square test taking p-value<0.05 as significant. Data was stratified for BMI (Normal, overweight and Obese).After stratification chi-square test was applied keeping a p value < 0.05 as significant. Results: In Group-A mean age of women was 28.18±6.58 years. In Group-B mean age of women was 27.08±5.15 years. In Group-A ovulation induction rate was much higher as compared to that of Group-B women. i.e. (89% vs. 60%). p-value=0.000. Ovulation induction rate was significantly higher with Letrozole+ Metformin in women who were having normal BMI, overweight & obese as compared to that of Letrozole alone. Conclusion: Letrozole with metformin is more effective for the ovulation Induction females presenting with polycystic ovarian Syndrome as compared to letrozole alone.()","PeriodicalId":11923,"journal":{"name":"Esculapio","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44481258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Esculapio
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1